RESUMO
Myricetin (3,3',4',5,5',7-hexahydroxyflavone), a major flavonoid in berries and red wine, has been recently used as a health food supplement based on its antioxidant and antitumor properties. We report here that myricetin preferentially exerts inhibitory effects on gastric H+, K+-ATPase. Myricetin inhibited H+, K+-ATPase with a sub-micromolar IC50 value in an enzyme assay using freeze-dried tubulovesicles prepared from hog stomach. Na+, K+-ATPase and Ca2+-ATPase were also inhibited by myricetin in a dose-dependent manner, but the IC50 values for these enzymes were approximately an order of magnitude higher compared to the H+, K+-ATPase. In structure-inhibitory functional analysis of sixteen myricetin derivatives, several phenolic hydroxy groups attached to the flavonoid backbone were highlighted as essential modifications for the inhibition of P2-type ATPases. Furthermore, oral administration of myricetin significantly attenuated histamine-induced gastric acid secretion in an in vivo mouse assessment. Therefore, myricetin derivatives seem to be useful seed compounds for developing new drugs and supplements to alleviate gastric acid secretion.
Assuntos
Produtos Biológicos/farmacologia , Flavonoides/farmacologia , ATPase Trocadora de Hidrogênio-Potássio/metabolismo , Inibidores da Bomba de Prótons/farmacologia , Estômago/enzimologia , Animais , Produtos Biológicos/química , Cálcio/metabolismo , Flavonoides/química , Ácido Gástrico/metabolismo , Mucosa Gástrica/metabolismo , Inibidores da Bomba de Prótons/química , Bombas de Próton/metabolismo , ATPase Trocadora de Sódio-Potássio/metabolismoRESUMO
We established a facile access to an unexplored mirror-image library of chiral natural product derivatives using d-protein technology. In this process, two chemical syntheses of mirror-image substances including a target protein and hit compound(s) allow the lead discovery from a virtual mirror-image library without the synthesis of numerous mirror-image compounds.
Assuntos
Produtos Biológicos/química , Produtos Biológicos/farmacologia , Avaliação Pré-Clínica de Medicamentos/métodos , Bibliotecas de Moléculas Pequenas/química , Bibliotecas de Moléculas Pequenas/farmacologia , Modelos Moleculares , Conformação Proteica , Estereoisomerismo , Interface Usuário-ComputadorRESUMO
Neurokinin B (NKB) regulates the release of gonadotropin-releasing hormone (GnRH) via activation of the neurokinin-3 receptor (NK3R). We evaluated the biological stability of NK3R selective agonists to develop novel NK3R agonists to regulate reproductive functions. On the basis of degradation profiles, several peptidomimetic derivatives were designed. The modification of senktide with (E)-alkene dipeptide isostere generated a novel potent NK3R agonist with high stability and prolonged bioactivity.
Assuntos
Neurocinina B/análogos & derivados , Fragmentos de Peptídeos/agonistas , Peptidomiméticos/farmacologia , Receptores da Neurocinina-3/agonistas , Substância P/análogos & derivados , Animais , Feminino , Cabras , Humanos , Hipotálamo/metabolismo , Concentração Inibidora 50 , Ovariectomia , Fragmentos de Peptídeos/classificação , Fragmentos de Peptídeos/metabolismo , Peptídeo Hidrolases/metabolismo , Peptidomiméticos/química , Estabilidade Proteica , Soro/metabolismo , Substância P/agonistas , Substância P/classificação , Substância P/metabolismo , SuínosRESUMO
The lack of small animal models for the evaluation of anti-human immunodeficiency virus type 1 (HIV-1) agents hampers drug development. Here, we describe the establishment of a simple and rapid evaluation system in a rat model without animal infection facilities. After intraperitoneal administration of test drugs to rats, antiviral activity in the sera was examined by the MAGI assay. Recently developed inhibitors for HIV-1 entry, two CXCR4 antagonists, TF14016 and FC131, and four fusion inhibitors, T-20, T-20EK, SC29EK, and TRI-1144, were evaluated using HIV-1(IIIB) and HIV-1(BaL) as representative CXCR4- and CCR5-tropic HIV-1 strains, respectively. CXCR4 antagonists were shown to only possess anti-HIV-1(IIIB) activity, whereas fusion inhibitors showed both anti-HIV-1(IIIB) and anti-HIV-1(BaL) activities in rat sera. These results indicate that test drugs were successfully processed into the rat sera and could be detected by the MAGI assay. In this system, TRI-1144 showed the most potent and sustained antiviral activity. Sera from animals not administered drugs showed substantial anti-HIV-1 activity, indicating that relatively high dose or activity of the test drugs might be needed. In conclusion, the novel rat system established here, "phenotypic drug evaluation", may be applicable for the evaluation of various antiviral drugs in vivo.
Assuntos
Fármacos Anti-HIV/administração & dosagem , HIV-1/efeitos dos fármacos , Sequência de Aminoácidos , Animais , Fármacos Anti-HIV/sangue , Fármacos Anti-HIV/farmacocinética , Disponibilidade Biológica , Avaliação Pré-Clínica de Medicamentos , Enfuvirtida , Proteína gp41 do Envelope de HIV/administração & dosagem , Células HeLa , Humanos , Injeções Intraperitoneais , Cinética , Dados de Sequência Molecular , Fragmentos de Peptídeos/administração & dosagem , Peptídeos/administração & dosagem , Peptídeos Cíclicos/administração & dosagem , Ratos , Receptores CXCR4/antagonistas & inibidores , Fatores de Tempo , Internalização do Vírus/efeitos dos fármacosRESUMO
Entry of human immunodeficiency virus type 1 (HIV-1) into target cells is mediated by its envelope protein gp41 through membrane fusion. Interaction of two extra-virion heptad repeats (HRs) in the gp41 plays a pivotal role in the fusion, and its inhibitor, enfuvirtide (T-20), blocks HIV-1 entry. To identify agents that block HIV-1 fusion, two screening methods based on detection and quantification by the enzyme-linked immunosorbent assay (ELISA) principle have been established. One method uses an alkaline phosphatase (ALP)-conjugated antibody (Ab-ELISA) and the other uses an ALP-fused HR (F-ELISA) to detect and quantify the interaction of the two HRs. The F-ELISA was more simple and rapid, since no ALP-conjugated antibody reaction was required. Both ELISAs detected all the fusion inhibitors tested except for T-20. Interaction of the two HRs was observed in both ELISAs, even in the presence of 10% dimethyl sulfoxide. Ab-ELISA performed best in a pH ranging from 6 to 8, while F-ELISA performed best at a pH ranging from 7 to 8. These results indicate that both established ELISAs are suitable for the identification of HIV-1 fusion inhibitors.